Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher

Reuters

8小時前

Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher

Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2586621476"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2586621476\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2586621476?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 15:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2586621476","market":"nz","top_or_hot":-1,"title":"Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSaniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-11-27 15:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR資本管理(全球第二大對沖基金)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nNDL2ZWX7v:1","article_id":"2586621476","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2586621476","pubTimestamp":1764226851,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Saniona AB reported revenue of SEK 410.7 million for the third quarter  2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC","JAZZ":"爵士制药","IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4532":"文艺复兴科技持仓","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC"},"translate_title":"Saniona AB 2025年第三季度收入飙升至4.107亿瑞典克朗，增长近57倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JAZZ":0.9},"content_text":"Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n    \n\n        Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}